ApoA-based chronic lymphocytic leukemia prognosis risk assessment system and application thereof
A risk assessment system and lymphocyte technology, applied in the field of chronic lymphocytic leukemia prognostic risk assessment system, can solve problems such as incurable CLL
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0058] 1. Materials and Methods
[0059] 1.1 Patient
[0060] Our study included 150 patients with CLL newly diagnosed at Shandong Provincial Hospital Affiliated to Shandong University from January 2010 to December 2019. All patients met the revised diagnostic criteria of the International Workshop on Chronic Lymphocytic Leukemia (IWCLL). The definitions of overall survival (OS) and progression-free survival (PFS) were also based on this. The last follow-up was in April 2020. This study was approved by the Hospital Ethics Committee of Provincial Hospital Affiliated to Shandong University. All participants signed the informed consent. All data are carried out following the Declaration of Helsinki.
[0061] 1.2 Cell lines and reagents
[0062] The human p53 deletion / mutant CLL cell line MEC1 cells and the human p53-broad CLL cell line EHEB cells were obtained from Moores Cancer Center, University of California, San Diego, and the American Type Culture Collection (ATCC), re...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com